Pregabalin Capsule
Product Images NDC 71335-1791

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71335-1791). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713351791)

This is a medication for which each capsule contains 25mg of Pregabalin, USP. It should be stored at room temperature of 20°-25°C (68°-77°F) and kept out of reach of children. The medication is sold in a bottle with 30 capsules that can only be obtained with a prescription. The label also contains safety information and identification details, including the NDC (National Drug Code) number.*

FDA Label Image

Label (Lbl7133517912)

This text seems to be a comparison between two medication packages, one being "Pachaged by Bryant Ranck Prepack" and the other "Lyrica 25mg (CV) Capsule" by Hetero Labs Limited. It also includes information about the quantity, expiration date, and NDC code for the Lyrica package. The text provides details about storage temperature and a reminder to keep all drugs out of reach of children. The last line seems to be a product code or UPC.*

FDA Label Image

Logo (Logo)

FDA Label Image

Pregabalinfigure1 (Pregabalinfigure1)

FDA Label Image

Pregabalinfigure10 (Pregabalinfigure10)

FDA Label Image

Pregabalinfigure11 (Pregabalinfigure11)

FDA Label Image

Pregabalinfigure12 (Pregabalinfigure12)

FDA Label Image

Pregabalinfigure2 (Pregabalinfigure2)

FDA Label Image

Pregabalinfigure3 (Pregabalinfigure3)

FDA Label Image

Pregabalinfigure4 (Pregabalinfigure4)

This text appears to be a chart or graph showing the percentage of patients who improved with Pregabalin and Placebo, with varying dosages of Pregabalin administered three times per day. The chart includes a numbered scale on the x-axis and the percentage of patients who improved on the y-axis. No further information is available from the provided text.*

FDA Label Image

Pregabalinfigure5 (Pregabalinfigure5)

FDA Label Image

Pregabalinfigure6 (Pregabalinfigure6)

FDA Label Image

Pregabalinfigure7 (Pregabalinfigure7)

FDA Label Image

Pregabalinfigure9 (Pregabalinfigure9)

The graph displays the percentage of patients who showed improvement in pain from baseline after receiving different doses of pregabalin and placebo. The x-axis represents the daily dosage of pregabalin and the y-axis shows the percentage of improvement in pain. The graph indicates that patients who received pregabalin at a dose of 600mg showed the highest percentage of improvement in pain.*

FDA Label Image

Pregabalinstructure (Pregabalinstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.